What is Exploramed?
ExploraMed operates as a dedicated incubator focused on pioneering patient-driven solutions for persistent medical challenges. The company's core mission is to elevate patients' quality of life through the development of innovative, cost-effective device solutions. By fostering an environment that challenges conventional thinking, ExploraMed has successfully launched eight distinct companies across four funding cycles. Their strategic partnerships with leading entities in the medical technology industry highlight their commitment to advancing healthcare through technological innovation, always with a primary focus on patient needs.
How much funding has Exploramed raised?
Exploramed has raised a total of $47.5M across 3 funding rounds:
Private Equity
$18.5M
Private Equity
$14M
Private Equity
$15M
Private Equity (2008): $18.5M with participation from NEA and Morgenthaler Partners
Private Equity (2014): $14M led by New Enterprise Associates
Private Equity (2015): $15M supported by NEA
Key Investors in Exploramed
NEA
NEA (New Enterprise Associates) is a prominent venture capital firm known for its significant investments across various stages and sectors, including technology and healthcare. They are recognized for their strategic approach to building companies.
Morgenthaler Partners
Morgenthaler Partners is a venture capital and private equity firm with a long history of investing in information technology and life sciences. They focus on supporting entrepreneurs in scaling their businesses.
New Enterprise Associates
New Enterprise Associates (NEA), established in 1977, is a venture capital firm that actively supports entrepreneurs in building and scaling their companies, with a strong presence in the technology and healthcare industries.
What's next for Exploramed?
The significant enterprise-level backing and recent strategic investment position Exploramed for accelerated growth and further innovation in the medical device sector. This capital infusion is expected to fuel the development of new patient-centric solutions and potentially expand the company's incubator model to address a broader range of medical problems. Exploramed's strategic approach, emphasizing patient needs and cost-effectiveness, suggests a continued focus on disrupting traditional healthcare paradigms and solidifying its role as a key player in medical technology advancement. Future endeavors will likely involve scaling existing ventures and identifying new opportunities for impactful medical device creation.
See full Exploramed company page
